endo-8-Azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride
≥95%
- Product Code: 85660
CAS:
63516-30-3
| Molecular Weight: | 373.87 g./mol | Molecular Formula: | C₂₁H₂₄ClNO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD13194790 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, stored under inert gas |
Product Description:
This compound is primarily utilized in the field of pharmacology due to its anticholinergic properties. It is often employed in the treatment of conditions related to excessive cholinergic activity, such as gastrointestinal spasms, motion sickness, and certain types of poisoning. Additionally, it is used in ophthalmic procedures to induce mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle), which are essential for detailed eye examinations and surgeries. Its ability to block acetylcholine receptors makes it effective in managing symptoms of Parkinson's disease and other movement disorders. In some cases, it is also administered preoperatively to reduce salivary and bronchial secretions, ensuring a safer anesthetic process.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $114.97 |
+
-
|
| 1.000 | 10-20 days | $287.42 |
+
-
|
| 5.000 | 10-20 days | $886.77 |
+
-
|
| 10.000 | 10-20 days | $1,480.21 |
+
-
|
endo-8-Azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride
This compound is primarily utilized in the field of pharmacology due to its anticholinergic properties. It is often employed in the treatment of conditions related to excessive cholinergic activity, such as gastrointestinal spasms, motion sickness, and certain types of poisoning. Additionally, it is used in ophthalmic procedures to induce mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle), which are essential for detailed eye examinations and surgeries. Its ability to block acetylcholine receptors makes it effective in managing symptoms of Parkinson's disease and other movement disorders. In some cases, it is also administered preoperatively to reduce salivary and bronchial secretions, ensuring a safer anesthetic process.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :